NDC 0006-4045-41

GARDASIL 40 ug/.5mL

Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant · INJECTION, SUSPENSION

No Recall History

GARDASIL is a injection, suspension containing human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant at a strength of 40 ug/.5mL. Manufactured by Merck Sharp & Dohme LLC.

Key Facts

Brand Name: GARDASIL
Generic Name: Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
NDC Code (Package): 0006-4045-41
NDC Code (Product): 0006-4045
Manufacturer: Merck Sharp & Dohme LLC
Strength: 40 ug/.5mL
Dosage Form: INJECTION, SUSPENSION
Route: INTRAMUSCULAR
Marketing Status
Application #: BLA125126
Marketing Start: 06/08/2006

Recall History

No Recall History

View Full Drug Page

GARDASIL — All Packages

Not medical advice. This information is for reference only. Always consult your doctor or pharmacist.